About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Our research group is accredited by the Agency for Management of University and Research Grants (AGAUR) in Catalonia, and focuses on two main areas of interest which are related to Solid Organ Transplantation and especially Kidney, and in clinical Nephrology. We tackle these areas from an innovative perspective, both basic-experimental and mechanistic, always with a translational goal. On the one hand, we investigate, develop, and use novel diagnostic and therapeutic technologies to decipher and target main molecular and immune mechanisms of transplant rejection as well as the immune susceptibility to opportunistic infections and malignancies. Also, a main task force of the group is devoted to better understand the main mechanisms involved in certain autoimmune glomerular diseases and idiopathic nephrotic syndrome as well as in diabetic kidney disease, having a specific interest in the role of the renin-angiotensin system. Our ultimate goal is to improve the management and care of patients suffering from kidney diseases as well as their quality of life, reducing associated morbidity and mortality.
PMID: 35384924 Journal: TRANSPLANTATION Year: 2022 Reference: Transplantation. 2022 Jul 1;106(7):1430-1439. doi: 10.1097/TP.0000000000004119. Epub 2022 Apr 1. Impact factor: 4.939 Publication type: Paper in international publication Authors: Mazuecos, Auxiliadora, Villanego, Florentino, Zarraga, Sofia, Lopez, Veronica, Oppenheimer, Federico, Llinas-Mallol, Laura, Moina, Inigo, Alcalde, Guillermo, Sanchez-Alvarez, Emilio, Pascual, Julio et al. DOI: 10.1097/TP.0000000000004119
PMID: 35373130 Journal: Kidney360 Year: 2022 Reference: Kidney360. 2021 Dec 3;3(2):293-306. doi: 10.34067/KID.0006612021. eCollection 2022 Feb 24. Impact factor: 0 Publication type: Paper in international publication Authors: Avello, Alejandro, Lightstone, Liz, Turner-Stokes, Tabitha, Griffith, Megan, Torras, Joan, Martinez Valenzuela, Laura, Bestard, Oriol, Geddes, Colin, Flossmann, Oliver, Budge, Kelly L et al. DOI: 10.34067/KID.0006612021
PMID: 35373449 Journal: CTS-Clinical and Translational Science Year: 2022 Reference: Clin Transl Sci. 2022 Jun;15(6):1544-1555. doi: 10.1111/cts.13276. Epub 2022 Apr 19. Impact factor: 4.689 Publication type: Paper in international publication Authors: Charco, Ramon, Dopazo, Cristina, Bilbao, Itxarone, Garcia, Sonia, Gomez-Gavara, Concepcion, Caralt, Mireia, Campos-Varela, Isabel, Castells, Lluis, Hidalgo, Ernest, Moreso, Francisco et al. DOI: 10.1111/cts.13276
PMID: 35320154 Journal: TRANSPLANTATION Year: 2022 Reference: Transplantation. 2022 May 1;106(5):1012-1023. doi: 10.1097/TP.0000000000004075. Epub 2022 Apr 26. Impact factor: 4.939 Publication type: Paper in international publication Authors: Bemelman, Frederike J, du Buf-Vereijken, Peggy W G, van Ginneken, Betty, Maas, Nanda, Vogt, Liffert, van Jaarsveld, Brigit C, Klingenberg-Salahova, Farah, Verhofstede, Sabine, Vervloet, Marc G, Nurmohamed, Azam et al. DOI: 10.1097/TP.0000000000004075
PMID: 33815780 Journal: Clinical Kidney Journal Year: 2021 Reference: Clin Kidney J. 2021 Mar 26;14(Suppl 1):i21-i29. doi: 10.1093/ckj/sfab030. eCollection 2021 Mar. Impact factor: 4.452 Publication type: Review in international publication Authors: Toapanta, Nestor, Torres, Irina B, Sellares, Joana, Chamoun, Betty, Seron, Daniel, Moreso, Francesc et al. DOI: 10.1093/ckj/sfab030
PMID: 33815779 Journal: Clinical Kidney Journal Year: 2021 Reference: Clin Kidney J. 2021 Mar 26;14(Suppl 1):i1-i5. doi: 10.1093/ckj/sfab039. eCollection 2021 Mar. Impact factor: 4.452 Publication type: Editorail in international publication Authors: Soler, Maria Jose, Batlle, Daniel et al. DOI: 10.1093/ckj/sfab039
PMID: 33819521 Journal: MOLECULAR AND CELLULAR ENDOCRINOLOGY Year: 2021 Reference: Mol Cell Endocrinol. 2021 Jun 1;529:111268. doi: 10.1016/j.mce.2021.111268. Epub 2021 Apr 2. Impact factor: 4.102 Publication type: Editorail in international publication Authors: Soler, Maria Jose, Batlle, Daniel et al. DOI: 10.1016/j.mce.2021.111268
PMID: 33098132 Journal: JOURNAL OF CLINICAL ULTRASOUND Year: 2021 Reference: J Clin Ultrasound. 2021 May;49(4):390-394. doi: 10.1002/jcu.22939. Epub 2020 Oct 24. Impact factor: 0.91 Publication type: Letter or abstract Authors: Escudero-Fernandez, Jose Miguel, Bolufer Cardona, Monica, Perez Lafuente, Mercedes, Montealegre, Carolina, Uriarte, Iciar, Serres-Creixams, Xavier et al. DOI: 10.1002/jcu.22939
The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.
Hypertension, a key risk factor for heart disease that contributes significantly to cardiovascular mortality and morbidity and damage to vital organs, was the focus of this multi-centre study.
The new findings were presented at the American Society of Nephrology's Kidney Week 2024 meeting in San Diego and simultaneously published in the prestigious journal Nature Medicine.
